Please use this identifier to cite or link to this item:
Title: Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon
Authors: Zahwe, Mariam
El Sammak, Aya
Ataya, Karim
Jabbour, Christelle
Bsat, Ayman
Hafez, Bassel
Atallah, Christine
Kheil, Mira
Maktabi, Mohamad Ali
Hassan, Bashar
Panossian, Vahe
Assi, Hazem
Abbas, Jaber
Sbaity, Eman
Affiliations: Faculty of Medicine 
Keywords: Breast cancer
Neoadjuvant therapy
Sentinel lymph node biopsy
Issue Date: 2024-02-21
Part of: Cancer Medicine
Volume: 13
Issue: 1
The feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in initially node-positive patients is still controversial. We aim to evaluate the oncologic outcomes of SLNB after NACT and further compare the results between those who were initially node-negative and node-positive.
DOI: 10.1002/cam4.6868
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

Record view(s)

checked on Apr 22, 2024

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.